All data are based on the daily closing price as of December 5, 2024
h

Humedix

200670.KQ
23.20 USD
0.02
+0.09%

Overview

Last close
23.20 usd
Market cap
239.11M usd
52 week high
31.86 usd
52 week low
18.29 usd
Target price
38.13 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
3.1393
Price/Book Value
1.5553
Enterprise Value
171.88M usd
EV/Revenue
1.5106
EV/EBITDA
5.2839

Key financials

Revenue TTM
78.37M usd
Gross Profit TTM
31.12M usd
EBITDA TTM
19.96M usd
Earnings per Share
N/A usd
Dividend
0.41 usd
Total assets
234.38B usd
Net debt
N/A usd

About

Humedix Co., Ltd. engages in the manufacture and sale of various pharmaceutical products in South Korea. The company offers prescription medicines, active pharmaceutical ingredients, medical devices, cosmetic, and health functional food products. It is also involved in manufacture and distribution of anticancer drugs. The company was formerly known as HVLS Co., Ltd. and changed its name to Humedix Co., Ltd. in 2010. Humedix Co., Ltd. was founded in 2002 and is headquartered in Seongnam-si, South Korea.
  • Symbol
    200670.KQ
  • Exchange
    KQ
  • Isin
    KR7200670008
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
  • Headquarter
    Seongnam-si
  • Web site
    https://humedix.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top